ArticleHaematologica2022

Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study.

Marie Emilie Dourthe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.